A study led by UCLA Health Jonsson Comprehensive Cancer Center researchers found that using a combination of experimental immunotherapy drugs with chemotherapy significantly improves progression-free survival and overall survival for patients with metastatic colorectal cancer who have previously undergone standard chemotherapy treatment when compared to those who received the targeted therapy regorafenib alone.
Doctors use precision medicine to show melanoma drugs can shrink rare brain tumor by 90%
By going down to the molecular level, doctors have uncovered a way to treat tumors caused by a rare brain cancer using medicines that already
July 13, 2023